Drug Design and Bioinformatics Unit, Department of Medical Biotechnology, Biotechnology Research Center, Pasteur Institute of Iran, Tehran, Iran.
Infect Disord Drug Targets. 2024;24(8):e290124226467. doi: 10.2174/0118715265270637240107153121.
Severe COVID-19 or severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a kind of viral pneumonia induced by infection with the coronavirus that causes ARDS. It involves symptoms that are a combination of viral pneumonia and ARDS. Antiviral or immunosuppressive medicines are used to treat many COVID-19 patients. Several drugs are now undergoing clinical studies in order to see if they can be repurposed in the future.
In this study, biomarker-targeted methodologies, such as target/ molecule virtual screening by docking technique and drug repositioning strategy, as well as data mining approach and meta-analysis of investigational data, were used.
In silico findings of used combination of drug repurposing and high-throughput docking methods presented acetaminophen, ursodiol, and β-carotene as a three-drug therapy regimen to treat ARDS induced by viral pneumonia in addition to inducing direct antiviral effects against COVID-19 viral infection.
In the current study, drug repurposing and high throughput docking methods have been employed to develop combination drug regimens as multiple-molecule drugs for the therapy of COVID-19 and ARDS based on a multiple-target therapy strategy. This approach offers a promising avenue for the treatment of COVID-19 and ARDS, and highlights the potential benefits of drug repurposing in the fight against the current pandemic.
严重的 COVID-19 或严重急性呼吸综合征冠状病毒 2（SARS-CoV-2）是由冠状病毒感染引起的病毒性肺炎，可导致急性呼吸窘迫综合征（ARDS）。它涉及到病毒性肺炎和 ARDS 的症状组合。抗病毒或免疫抑制药物用于治疗许多 COVID-19 患者。目前正在进行一些药物的临床研究，以观察它们将来是否可以被重新用于治疗。
在这项研究中，使用了生物标志物靶向方法，如对接技术的靶标/分子虚拟筛选和药物重定位策略，以及数据挖掘方法和研究数据的荟萃分析。
使用药物重定位和高通量对接方法的计算研究结果表明，对乙酰氨基酚、熊去氧胆酸和β-胡萝卜素联合治疗可作为一种三药治疗方案，用于治疗病毒性肺炎引起的 ARDS，同时对 COVID-19 病毒感染具有直接抗病毒作用。
在目前的研究中，药物重定位和高通量对接方法已被用于开发联合药物方案，作为针对 COVID-19 和 ARDS 的多分子药物，基于多靶点治疗策略。这种方法为治疗 COVID-19 和 ARDS 提供了一个有前途的途径，并强调了药物重新定位在应对当前大流行中的潜在益处。
